Ruud H Wijdeven

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Epidermal Growth Factor Receptor

Peripheral Blood

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Ruud H Wijdeven, Sietse J Luk, Tom A W Schoufour, Sabina Y van der Zanden, Marta Cabezuelo, Mirjam H M Heemskerk, Jacques J C Neefjes
Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1. Journal of immunology (Baltimore, Md. : 1950) (2023)
Yuanzhuo Gu, Zhengkui Zhang, Marcel G M Camps, Ferry Ossendorp, Ruud H Wijdeven, Peter Ten Dijke
Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells. Science advances 9 (28) (2023)
Ruud H Wijdeven, Birol Cabukusta, Felix M Behr, Xueer Qiu, Deeba Amiri, Daniel M Borras, Ramon Arens, Yun Liang, Jacques J C Neefjes
CRISPR Activation Screening Identifies VGLL3-TEAD1-RUNX1/3 as a Transcriptional Complex for PD-L1 Expression. Journal of immunology (Baltimore, Md. : 1950) 209 (5) (2022)